| Literature DB >> 34028587 |
Linda Mullins1, Jessica Ivy2, Mairi Ward2, Olav Tenstad3, Helge Wiig3, Kento Kitada4, Jon Manning5, Natalia Rakova6, Dominik Muller6,7, John Mullins2.
Abstract
We discovered high Na+ and water content in the skin of newborn Sprague-Dawley rats, which reduced ~ 2.5-fold by 7 days of age, indicating rapid changes in extracellular volume (ECV). Equivalent changes in ECV post birth were also observed in C57Bl/6 J mice, with a fourfold reduction over 7 days, to approximately adult levels. This established the generality of increased ECV at birth. We investigated early sodium and water handling in neonates from a second rat strain, Fischer, and an Hsd11b2-knockout rat modelling the syndrome of apparent mineralocorticoid excess (SAME). Despite Hsd11b2-/- animals exhibiting lower skin Na+ and water levels than controls at birth, they retained ~ 30% higher Na+ content in their pelts at the expense of K+ thereafter. Hsd11b2-/- neonates exhibited incipient hypokalaemia from 15 days of age and became increasingly polydipsic and polyuric from weaning. As with adults, they excreted a high proportion of ingested Na+ through the kidney, (56.15 ± 8.21% versus control 34.15 ± 8.23%; n = 4; P < 0.0001), suggesting that changes in nephron electrolyte transporters identified in adults, by RNA-seq analysis, occur by 4 weeks of age. Our data reveal that Na+ imbalance in the Hsd11b2-/- neonate leads to excess Na+ storage in skin and incipient hypokalaemia, which, together with increased, glucocorticoid-induced Na+ uptake in the kidney, then contribute to progressive, volume contracted, salt-sensitive hypertension. Skin Na+ plays an important role in the development of SAME but, equally, may play a key physiological role at birth, supporting post-natal growth, as an innate barrier to infection or as a rudimentary kidney.Entities:
Keywords: Hsd11b2; Hypertension; Knockout; Neonatal; Newborn; Rat; Salt-sensitive; Skin
Mesh:
Substances:
Year: 2021 PMID: 34028587 PMCID: PMC8164623 DOI: 10.1007/s00424-021-02582-7
Source DB: PubMed Journal: Pflugers Arch ISSN: 0031-6768 Impact factor: 3.657
Fig. 1Skin Na+ and water content during development in Sprague–Dawley (SD) (a) skin Na+ (mmol/g dry weight; *** = 0.0002; **** < 0.0001) (b) skin water (ml/g dry weight; *** = 0.0009; **** < 0.0001), and C57Bl/6J mice (c) skin Na+ (mmol/g dry weight; *** = 0.0003; ** = 0.0047) and (d) skin water (ml/g dry weight; *** < 0.0002) (n = 6–9 per group; two-way ANOVA with Kruskal Wallis and Dunn’s multiple comparison test)
Fig. 2Skin electrolytes and water content during development. a skin Na+ (mmol/g dry weight; note logarithmic scale); b skin K+ (mmol/g dry weight; c skin water (ml/g dry weight); d skin Na+ (mmol/ml); e skin K+ (mmol/ml); f skin electrolytes (Na+K+(mmol/ml)). (n = 3–6 per group per time point; two-way ANOVA with Sidak’s multiple comparison test * < 0.05; ** < 0.01; *** < 0.001)
Correlation coefficients (r), coefficients of determination (r2) and probability (p) between variables (column 1), and skin Na+ per g dry weight
| variables | CON | Hsd2−/− | ||||
|---|---|---|---|---|---|---|
| r | r2 | p | r | r2 | p | |
| Total body Na+ g−1 dry weight | 0.627 | 0.393 | ns | 0.951 | 0.905 | 0.0035 |
| Total body Na+ + K+ g−1 dry weight | 0.439 | 0.193 | ns | 0.982 | 0.964 | 0.0005 |
| Total body water g−1 dry weight | 0.406 | 0.165 | ns | 0.989 | 0.978 | 0.0002 |
| Bone Na+ g−1 dry weight | − 0.911 | 0.83 | 0.0115 | − 0.865 | 0.748 | 0.026 |
Fig. 3Developmental changes in a blood pressure b haematocrit c plasma Na+, and d plasma K+ (minimum n = 3 per time point; unpaired t test; *** 0.0009; **** < 0.0001)
Fig. 4Metabolic study of post-weaned pups a daily water intake b daily urinary output c Na+/K+ ratio in urine (n = 4 per group; two-way ANOVA with Sidak’s multiple comparison test * < 0.05; ** < 0.01; **** < 0.0001)
Fig. 5Immunohistochemical analysis showing PC, IC, and intermediate cells stained with Aqp2 and V-Atpaseb1 antibodies in a control; b Hsd2−/− section. The relative proportion of cell types in collecting ducts was counted between control and Hsd2−/− rats. The log-ratio of PC: IC and intermediate: IC are reported as means ± SD, at c ~ 5 weeks (n = 4), and d 24 weeks (n = 3). Significance between groups was assessed using multiple analysis of variance (p < 0.05 *). A decrease in the log-ratio of PC:IC indicates an overall decrease in the proportion of PCs present in the CD relative to ICs (the latter did not significantly change between WT and KO). Likewise, an increase in the log-ratio of intermediate: IC indicates an overall increase in the proportion of intermediate cells relative to ICs
Fig. 6Tissue a urea and b arginase assays. (KC = kidney cortex; KM = kidney medulla; n = 6 per group; Student’s t test; * < 0.015)
RNAseq data for genes involved in BP and ECV control
| Fold | q value | |
|---|---|---|
| Ren — renin | − 27.97 | 0 |
| Pappa2 — pappalysin 2 | − 8.28 | 0 |
| Ptgs2 — Cox2 | − 3.1 | 2.91E-10 |
| Aqp5 — aquaporin 5 | − 1.88 | 6.00E-05 |
| Aqp8 — aquaporin 8 | − 1.85 | 0.0008 |
| Nos1 — nNos | − 1.62 | 2.40E-09 |
| Agtr1b — angII receptor type 1b | − 1.48 | 0.005 |
| Aqp2 — aquaporin 2 | − 1.35 | 0.00779 |
| Gcgr — glucagon receptor | − 1.33 | 6.34E-05 |
| Nr3c2 — mineralocorticoid receptor | − 1.28 | 0.0013 |
| Aqp1 — aquaporin 1 | − 1.25 | 2.56E-03 |
| Avpr2 — arginine vasopressin receptor 2 | − 1.16 | 1.06E-01 |
| Slc2a2 — Glut2 | 1.32 | 1.41E-05 |
| Tgfb1 — transforming growth factor beta 1 | 1.42 | 7.61E-05 |
| Edn1 — endothelin 1 | 1.54 | 4.21E-05 |
| Avpr1a — arginine vasopressin receptor 1a | 1.63 | 2.88E-06 |
| Cldn7 — claudin 7; membrane protein; Cl permeation | 2.01 | 0 |
RNA-seq data for genes coding for nephron transporters
| Fold | q value | |
|---|---|---|
| Slc14a2 — urea transporter | − 6.4 | 9.00E-04 |
| Slc22a13 — organic/urate cation transporter | − 3.86 | 0 |
| Kcna4 — K voltage-gated channel | − 3.45 | 0 |
| Kcnq3 — K voltage-gated channel | − 2.61 | 0 |
| Slc4a5 — sodium bicarbonate | − 2.36 | 0.00015 |
| Slc2a4 — facilitated glucose transfer | − 2.4 | 0 |
| Atp1a4 — atpase Na/K transporter subunit a4 | − 2.13 | 0 |
| Scn1a — Na voltage-gated channel 1a | − 2.06 | 0.001 |
| Slc9a3 — Na–H exchanger | − 1.36 | 0 |
| Slc12a1 — Na K chloride cotransporter (NKCC2) | − 1.29 | 0.025 |
| Kcnj1 — ROMK channel | − 1.38 | 0 |
| Slc12a3 — Na-Cl cotransporter (NCC) | − 1.35 | 0.0016 |
| Slc20a1 — Na dependent Pi cotransporter | 1.27 | 3.00E-05 |
| Car4 — carbonic anhydrase | 1.29 | 0.0008 |
| Atp1a1 — atpase Na/K transporter subunit a1 (IC beta) | 1.34 | 0 |
| Slc4a8 — sodium bicarbonate (IC beta) | 1.4 | 0.0025 |
| Slc4a9 — AE4 (IC β) | 1.6 | 0 |
| Scnn1a — endothelial Sodium chloride (PC) | 1.67 | 0 |
| Kcne5 — K voltage-gated channel | 2.03 | 0.00093 |
| Slc26a4 — Cl/OH/HCo3 exchanger, Pendrin (IC β) | 2.04 | 0 |
| Trpv5 — transient potential cation channel | 2.46 | 0 |
| Kcnma1 — BK, K Ca activated channel, subunit α | 2.66 | 0 |
| Slc34a2 — sodium/phosphate co-transporter | 2.68 | 0 |
| Atp12a — ATPase H/K transporter (distal nephron) | 4.33 | 3.00E-05 |
| Trpv6 — transient potential cation channel | 8.89 | 0 |
RNA-seq data for genes involved in fibrosis/inflammation
| Fold | q value | |
|---|---|---|
| Fgg — fibrinogen gamma | 12.62 | 0 |
| Fgb — fibrinogen beta | 9.29 | 0 |
| C4b — complement component 4b | 9.17 | 0 |
| Spp1 — secreted phosphoprotein | 7.86 | 0 |
| Havcr1 — KIM-1 | 5.52 | 0 |
| C4a — complement component 4a | 5.16 | 0.00067 |
| Angptl4 — angiopoietin like 4 | 4.43 | 0 |
| Mmp7 — matrix metalloproteinase | 4.29 | 0 |
| Timp1 — tissue inhibitor of metalloproteinase | 4.11 | 0 |
| Fga — fibrinogen alpha | 3.97 | 0 |
| Mmp12 — matrix metalloproteinase | 3.18 | 0 |
| Col1a1 — collagen | 2.59 | 0 |
| Col28a1 — collagen | 2.44 | 0 |
| Fbln1 — fibulin; ECM | 2.32 | 0 |
| Mmp8 — matrix metalloproteinase | 2.34 | 0 |
| Fn1 — fibronectin 1 | 2.26 | 0 |
| Mmp2 — matrix metalloproteinase | 2.09 | 0 |
| Col3a1 — collagen | 2.08 | 0 |
| Col8a1 — collagen | 2.07 | 0 |